By Dr. Joseph Mercola - October 15, 2021

As we enter into the 10th month of COVID injections, what can we tell about their effectiveness? Are they working?

According to data from Israel — which is the best in the world at this point, thanks to the Israelis’ dedication to data collection and transparency — it seems the news is anything but good, and that is a profoundly serious understatement.

In an October 3, 2021, substack article, Alex Berenson dissects a recent Eurosurveillance report about a SARS-CoV-2 Delta outbreak in an Israeli dialysis ward. Eurosurveillance is a journal published by the European Centers for Disease Control.

Hospital Outbreak Reveals The Ineffectiveness Of COVID Jabs

An unidentified dialysis patient came in for scheduled treatment with fever and cough. Over the course of several days, his condition continued to deteriorate, but he remained in the dialysis unit at the Meir Medical Center.

COVID measures at the hospital includes routine wearing of full protective equipment by all COVID unit staff, including N-95 mask, face shield, gown, gloves and hair cover. Patients also wear surgical masks when in the same room as another patient.

By the time the sick patient was tested and diagnosed with COVID-19, he had a PCR cycle threshold (CT) of 13.6, which means he had a viral load approximately 1 million times higher than a person with mild infection.

The infection spread rapidly among patients and staff, spreading from the dialysis ward to the COVID-19 ward and other units. At the time of the outbreak, 238 out of 248 (96%) of the exposed patients and staff had been fully vaccinated with Pfizer’s mRNA vaccine. Of the 238 fully vaccinated individuals, 39 (16%) were infected, as were three of the 10 unvaccinated individuals who got exposed.

Near-Maximum Vaccination Rate Yet No Herd Immunity

While all of the sickened staff recovered, five infected patients died and nine turned into severe or critical cases. All of the dead and severe/critical cases were fully vaccinated. Two unvaccinated patients who were infected only had mild illness. As noted by the authors:

“The calculated attack rate among all exposed patients and staff was 10.6% (16/151) for staff and 23.7% (23/97) for patients, in a population with 96.2% vaccination rate (238 vaccinated/248 exposed individuals).

Moreover, several transmissions probably occurred between two individuals both wearing surgical masks, and in one instance using full PPE, including N-95 mask, face shield, gown and gloves…

This nosocomial outbreak exemplifies the high transmissibility of the SARS-CoV-2 Delta variant among twice vaccinated and masked individuals. This suggests some waning of immunity, albeit still providing protection for individuals without comorbidities …

This communication … challenges the assumption that high universal vaccination rates will lead to herd immunity and prevent COVID-19 outbreaks…

In the outbreak described here, 96.2% of the exposed population was vaccinated. Infection advanced rapidly (many cases became symptomatic within 2 days of exposure), and viral load was high.

Another accepted view is that, when facing a possible mismatch between the SARS-CoV-2 variant and vaccine or waning immunity, the combination of vaccine and face mask should provide the necessary protection.

Although some transmission between staff members could have occurred without masks, all transmissions between patients and staff occurred between masked and vaccinated individuals, as experienced in an outbreak from Finland.”

This case tells us a couple of important things. First, that even in a population where more than 96 percent are fully vaccinated, outbreaks will occur. This means the shots are clearly not even remotely creating any kind of herd immunity. Indeed, there have been outbreaks even in populations where the vaccination rate was 100 percent.

Secondly, the unvaccinated who got sick had only mild illness, while the fully vaccinated all ended up with severe infection. The unvaccinated recovered without a problem while several of the fully vaccinated patients died.

Thirdly, it tells us masks, face shields and gloves provide little more than a false sense of security. Altogether, this report is evidence that everything we’re currently doing is foolishness.

COVID-Like Illness Among The Vaccinated

In the U.S., the data are far more manipulated, as this next section will reveal. The study in question, “Effectiveness of COVID-19 Vaccines in Ambulatory and Inpatient Care Settings,” was published September 8, 2021, in The New England Journal of Medicine.

The researchers identified a total of 103,199 hospitalizations between January 1, 2021, and June 22, 2021. Of those, 41,552 met the study criteria for inclusion (the real number is actually 41,159, as there’s a mathematical error). Included patients were 50 or older, and had “COVID-like illness” (CLI), defined as COVID symptoms and a positive PCR test.

Excluded hospitalizations that did not meet the study criteria were patients younger than 50, patients without vaccination record, repeat admissions, patients that had no COVID test results, and those who had received their second dose of mRNA injection (or first and only dose required of the Janssen vaccine) within the last 14 days and therefore were not considered fully vaccinated.

The exclusion of people who got the jab within 14 days of their hospitalization is more than regrettable and designed to create real misinformation and fraudulent results skewed in favor of the jab. Researchers have determined that you’re at increased risk of infection during the first 14 days, because you haven’t reached adequate antibody levels yet.

A Swedish study posted April 21, 2021, found “The estimated vaccine effectiveness in preventing infection ≥7 days after second dose was 86 percent but only 42 percent ≥14 days after a single dose.” While maximum effectiveness isn’t reached until the 14-day mark, why shouldn’t hospitalizations that occur within that two-week window count?

According to The New England Journal of Medicine report, the effectiveness of the mRNA shots against lab-confirmed SARS-CoV-2 infection, 14 or more days after injection, was 89 percent, on average. Effectiveness among those 85 and older, those with chronic medical conditions, as well as Black and Hispanic adults, ranged from 81 to 95 percent.

The effectiveness of the Janssen “vaccine” against lab-confirmed infection leading to hospitalization was 68 percent, and 73 percent against infection requiring emergency care. That sounds pretty good, but it doesn’t tell the whole story.

Digging Further Into The Data

In a Twitter thread, Ben M. double-checked and recalculated the vaccine efficacy, taking into account all CLI admissions, not just those where the patient had been vaccinated at least 14 days prior. When adding those previously excluded patients back in, Ben M. came up with a vaccine effectiveness rate of 13 percent.

He also discovered that if you look at how many people actually had a CLI clinical diagnosis code among the 41,552 included patients, the rate of diagnosis between the unvaccinated, the partially vaccinated and the fully vaccinated was nearly identical: 73% for the unvaccinated, 71 percent for the partially vaccinated and 72 percent for the fully vaccinated.

Here’s where it gets interesting . . .

[SNIP]